How did the evolution of protosynthesis take place from cyanobacteria, algae and plants?
Best insight from top research papers
The evolution of photosynthesis, a pivotal process for life on Earth, traces back to ancient cyanobacteria, which are recognized as the first organisms to perform oxygenic photosynthesis. This evolutionary lineage extends through algae to modern plants, highlighting a complex history of genetic and biochemical innovations. Cyanobacteria, with their ability to harness sunlight to produce oxygen, laid the foundational blueprint for photosynthetic mechanisms that were later inherited and refined by eukaryotic algae and plants. The primary event that significantly propelled this evolutionary trajectory was the endosymbiotic engulfment of a cyanobacterium by a eukaryotic host, giving rise to the first photosynthetic eukaryotes through primary endosymbiosis. This event not only introduced photosynthesis to eukaryotes but also set the stage for the diversification of algae and the eventual emergence of land plants. Molecular and phylogenetic analyses have shed light on the evolutionary relationships between the photosynthetic machinery of cyanobacteria, algae, and plants. For instance, the conservation of certain proteins and pigments across these groups underscores a shared evolutionary heritage. Proteins like plastocyanins and cytochromes have shown a remarkable degree of structural and functional conservation, indicating their central role in the photosynthetic apparatus across different lineages. Similarly, the biosynthesis of isoprenoids, crucial for photosynthesis, exhibits pathways inherited from prokaryotes to eukaryotes, further evidencing the transfer of photosynthetic capabilities from cyanobacteria to algae and plants. Moreover, the evolution of photosynthesis has been marked by the development and refinement of the photosystems and accessory pigments, such as chlorophylls and phycobilins, which play critical roles in light absorption and energy transfer. The diversification of these components has enabled a wide range of photosynthetic efficiencies and adaptations across different environments. In summary, the evolution of photosynthesis from cyanobacteria through algae to plants is a testament to the intricate interplay of endosymbiotic events, genetic inheritance, and biochemical innovation. This evolutionary path has not only been crucial for the development of the photosynthetic apparatus but has also significantly shaped the Earth's biosphere by enabling the oxygenic atmosphere that supports diverse life forms today.
Answers from top 4 papers
More filters
| Papers (4) | Insight |
|---|---|
21 Citations | The evolution of photosynthesis involved an early split forming the reaction center and ancestral inner antenna proteins, with CP43 lineage later giving rise to CP43' proteins in cyanobacteria. |
28 Sep 2007 20 Citations | The biosynthesis of open-chain tetrapyrroles in plants, algae, and cyanobacteria involves enzyme reactions converting protohaem to phycobilins like phytochromobilin, essential for light energy-harvesting and plant development. |
| Protein evolution studies suggest that cyanobacteria proteins evolve slower than those in algae and plants, indicating a possible evolutionary link in photosynthesis from cyanobacteria to eukaryotes. | |
01 Jan 2010 6 Citations | The evolution of photosynthesis involved endosymbiotic events where eukaryotes (green plants) evolved from prokaryotes (cyanobacteria), occurring between 2500 and 1000 million years ago. |
Related Questions
What are the genetic and biochemical mechanisms involved in polyketide synthesis in microalgae?5 answersPolyketide synthesis in microalgae involves complex genetic and biochemical mechanisms. Gene clusters in marine cyanobacteria encode enzymes like polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs). Type III PKSs in cyanobacteria show wide substrate specificity and simple reaction mechanisms, contributing to the production of diverse polyketides. These compounds play crucial roles in marine ecosystems and can be synthesized by gene clusters with specific domains for carbon chain extension and modification. Additionally, polyketoacyl-CoA thiolases catalyze non-decarboxylative condensation reactions in microorganisms, leading to the generation of functionalized polyketides. Understanding these genetic and biochemical processes is essential for exploring the biosynthesis of polyketides in microalgae and their potential applications in various fields.
What are the specific compounds that are considered prebiotics in cyanobacteria?5 answersCyanobacteria, a group of photosynthetic prokaryotes, have been identified as a promising source of prebiotic compounds due to their rich biochemical composition. Among the specific compounds that are considered prebiotics in cyanobacteria, polysaccharides stand out for their potential functional impacts on health. Microalgae, including cyanobacteria, are rich in carbohydrates, proteins, and polyunsaturated fatty acids, with their polysaccharides or derivatives being studied for their novel prebiotic source action in functional foods. These microalgae prebiotic polysaccharides are also explored for their antioxidant, anticancer, and antihypertensive bioactivities, highlighting their significance beyond nutritional supplementation.
Furthermore, the metabolic profiling of cyanobacteria, such as Nostoc muscorum, has revealed the presence of several sugars and oligosaccharides, which could contribute to their prebiotic properties. These compounds, along with lipids, amino acids, and peptides, underscore the diverse metabolic composition of cyanobacteria that can be harnessed for biotechnological exploitation, including the development of prebiotics.
In addition to polysaccharides, cyanobacteria produce a vast spectrum of bioactive compounds through their unique metabolic apparatus, such as Non-Ribosomal Peptide Synthetases (NRPSs), which contribute to their adaptative capacity and potential prebiotic effects. The production of complex non-ribosomal peptides, like anabaenopeptins, demonstrates the biochemical diversity of cyanobacteria and their potential as a source of novel prebiotics.
Overall, the specific compounds in cyanobacteria considered as prebiotics primarily include polysaccharides and oligosaccharides, with the potential inclusion of other bioactive metabolites produced through unique biosynthetic pathways. The exploration of these compounds for their prebiotic properties is an ongoing area of research, promising new functional food ingredients and supplements derived from cyanobacteria.
What are the enzymatic pathways involved in the biosynthesis of cyanobacterial exopolysaccharides?10 answersThe biosynthesis of cyanobacterial exopolysaccharides (EPS) involves complex enzymatic pathways that are crucial for their survival and adaptability in various environments. These pathways are orchestrated by a multitude of genes and enzymes that facilitate the production of unique heteropolysaccharides, which are instrumental in biofilm formation and heavy metal adsorption. Cyanobacteria, including strains like Nostoc sp. PCC7120, have been extensively studied to understand the genetic basis of EPS biosynthesis. These studies reveal that EPS biosynthesis occurs through multiple pathways, each involving a distinct set of genes and enzymes.
One of the key components in the biosynthesis of cyanobacterial EPS is the glycosyltransferase enzymes, which play a pivotal role in the polymerization process. These enzymes are responsible for the addition of monosaccharide units to the growing polysaccharide chain, a process that is regulated by cyclic dimeric GMP (c-di-GMP). The Pel polysaccharide system in Pseudomonas aeruginosa, for example, demonstrates a synthase-dependent pathway for polysaccharide secretion, highlighting the importance of glycosyltransferase domains in EPS production.
Furthermore, the study of Gloeocapsopsis sp. UTEX B3054 from the Atacama Desert has shed light on the genetic potential related to the biosynthesis and regulation of compatible solutes and polysaccharides. This includes a novel genomic arrangement associated with the recycling of trehalose and a diverse pool of glycosyltransferase enzymes, underscoring the complexity of the enzymatic pathways involved in EPS biosynthesis. These findings underscore the intricate network of enzymatic pathways and regulatory mechanisms that cyanobacteria employ to produce and regulate EPS, contributing to their resilience and ecological success in diverse environments.
What are the main secondary metabolites produced by cyanobacteria?10 answersCyanobacteria, a diverse group of photosynthetic bacteria, are prolific producers of a wide array of secondary metabolites, which play crucial roles in their survival and interaction with the environment. These metabolites are not only structurally diverse but also possess a range of biological activities, making them of significant interest for various applications, including pharmaceuticals. The main classes of secondary metabolites produced by cyanobacteria include non-ribosomal peptides (NRPs), polyketides (PKs), and hybrids of NRPs and PKs, which are synthesized through nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) systems, often involving mixed NRPS-PKS enzymatic pathways.
These compounds span a broad spectrum of chemical structures and bioactivities. For instance, cyanobacteria produce linear and cyclic depsipeptides, lipopeptides, macrocyclic polyketides, peptide-polyketide hybrid metabolites, cyclophane derivatives, and alkaloids. Among these, some notable examples include ambigols, malyngamides, majusculamide C, somocystinamide, apratoxin A, and dolastatin 15, which have been identified for their antibacterial, antifungal, antiprotozoal, and anticancer activities. Additionally, cyanobacteria are known to produce antifungal agents belonging to various chemical classes such as peptides, fatty acids, alkaloids, polyketides, and macrolides.
Moreover, cyanobacteria have developed unique metabolites like scytonemins and mycosporine-like amino acids, which serve as UV filters, protecting them from damaging solar radiation. The diversity of these metabolites is further exemplified by the production of glycolipids, macrolides, peptides, and polyketides, many of which have shown potential pharmacological uses, including anticancer bioactivities. This vast array of secondary metabolites, ranging from low molecular weight compounds like photoprotective mycosporine-like amino acids to complex structures such as cyanotoxins, highlights the biochemical versatility of cyanobacteria and their potential utility in various industries, including pharmaceuticals and cosmetics.
Did prokaryotes or archea come first?4 answersArchaea came first in the evolution of life on Earth. The origins and evolution of Archaea, Bacteria, and Eukarya have been a topic of debate, but phylogenomic studies suggest that Archaea is the first domain of life to diversify from a stem line of descent, representing the last universal common ancestor of cellular life. Comparative genomic and phylogenomic analyses support the co-evolution of ancestors of Euryarchaeota with those of Bacteria prior to the diversification of Eukarya. These analyses also show horizontal gene recruitments and informational process homologies, indicating a close relationship between Archaea and Bacteria. Additionally, the use of macromolecular structure and a new phylogenetic framework of analysis supports a consistent phylogenomic scenario in which the origin of diversified life can be traced back to the early history of Archaea.
PHA biosynthesis by cyanobacteria?3 answersPHA biosynthesis by cyanobacteria has been a topic of interest in biotechnological studies. Cyanobacteria are known for their high protein content, essential fatty acids, vitamins, and minerals, making their biomass a potential source for PHA production. Unusual polyhydroxyalkanoates (UnPHAs) are a particular group of PHAs that include PHAs obtained by physical modifications of naturally occurring polymers. These UnPHAs can be manipulated chemically or physically, and their biosynthetic particularities and characteristics have been analyzed. The biosynthetic machinery for PHA metabolism has been extensively studied, and at least five different PHA biosynthetic pathways have been identified. Genetic and molecular engineering have been used to develop optimum PHA producing organisms, with the aim of reducing production costs and increasing industrial applications. Strategies and possibilities for obtaining PHAs by fermentation of wild-type bacteria, mutants, and recombinant strains have been explored, as well as in vitro biosynthesis of PHA using purified polymerizing enzymes.